PAA 4.17% 17.3¢ pharmaust limited

Ann: Additional Phase 1 data suggest MPL may inhibit MND, page-72

  1. 12,151 Posts.
    lightbulb Created with Sketch. 6202
    100% exactly as previous Announcements from the Company .

    Look at the Market Reaction? didn't even breach 10c,,,

    After Channel 9 and Sky News interviews with the CEO we should see greater awareness...

    Already MPL is delivering more than Riluzole with Nil Adverse effects...

    Just require Cohort 4 results and the Trial is finished.... NZT

    6 days of dosing left for Cohort 4
    Last edited by NZ Trader: 22/08/23
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
17.3¢
Change
-0.008(4.17%)
Mkt cap ! $83.90M
Open High Low Value Volume
18.0¢ 18.0¢ 17.3¢ $59.77K 338.7K

Buyers (Bids)

No. Vol. Price($)
13 376984 17.0¢
 

Sellers (Offers)

Price($) Vol. No.
17.5¢ 25091 2
View Market Depth
Last trade - 15.42pm 13/09/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.